Digestive & Liver Diseases
Liver Diseases
Rafael Esteban Mur
Principal Investigators | Salvador Augustin Recio, Maria Buti Ferret, Juan Ignacio Esteban Mur, Joan Genescà Ferrer, Maria Martell Pérez-Alcalde, Beatriz Minguez Rosique, Celia Belen Perales Viejo, Francisco Rodríguez Frias, Victor Manuel Vargas Blasco | Researchers
José Altamirano Gómez, Lluis Castells Fusté, Antonio González Fernández, Jaume Guardia Massó, Josep Quer Sivila, Silvia Sauleda Oliveras, Lluís Viladomiu Catà | Researchers in training Miren Bravo Garmendia, Qian Chen, Maria Jose Fabrega Fernandez, Cristina Godoy Cruz, Maria Homs Riba, Mònica Pons Delgado, Begoña Santos García de Vicuñ, Macarena Simon-Talero Horga, David Tabernero Caellas, Manuel Torres Arauz, Meritxell Ventura Cots | Nursing, Technical, and Administrative Staff Susana Anton Calvo, Maria Blasi Fornaguera, Judit Carbonell Segura, Rosario Casillas Gomez, Damir Garcia Cehic, Monica Higuera Urbano, Leonardo Nieto Aponte, Mª Nieves Palomo Merchan, Mireia Pares Guerrero, Immaculada Raurell Saborit, Angeles Rico Blazquez, Laura Santos Figueroa, Maria Eugenia Soria Benito, Francisco Tena Frean, Maria Margarita Torrens Buscató, Marta Vila Salvador
Summary
The most important feature of 2015 for the group has been the advent of the new oral antiviral therapies for hepatitis C. Our group has been involved in many of pivotal studies to clinically develop these drugs and we have developed a new technology to correctly identify the genotypes and subtypes of HCV that it is becoming very useful to correctly treat patients and it is being used by many research centers in Spain.